Preferential/JJ
presentation/NN
of/IN
herpes/NN
simplex/NN
virus/NN
T-cell/NN
antigen/NN
by/IN
HLA/NN
DQA1*0501/DQB1*0201/NN
in/IN
comparison/NN
to/TO
HLA/NN
DQA1*0201/DQB1*0201/NN
./.

The/DT
HLA/NN
DQA1/NN
locus/NN
is/VBZ
polymorphic/JJ
./.
=====
Haplotypes/NNS
containing/VBG
HLA/NN
DQA1*0501/NN
,/,
but/CC
not/RB
HLA/NN
DQA1*0201/NN
,/,
together/RB
with/IN
HLA/NN
DQB1*0201/NN
are/VBP
associated/VBN
with/IN
Grave/NN
's/POS
disease/NN
and/CC
celiac/JJ
sprue/NN
./.
=====
In/IN
this/DT
report/NN
,/,
we/PRP
demonstrate/VBP
a/DT
functional/JJ
correlate/NN
of/IN
DQA1/NN
polymorphism/NN
./.
=====
T/NN
cells/NNS
infiltrating/VBG
a/DT
herpes/NN
simplex/NN
virus/NN
(/(
HSV/NN
)/)
lesion/NN
from/IN
a/DT
HLA/NN
DQ/NN
2,7/CD
individual/NN
yielded/VBD
a/DT
virus-specific/JJ
CD4+/JJ
clone/NN
restricted/VBN
by/IN
DQ2/NN
./.
=====
Presentation/NN
of/IN
viral/JJ
peptide/NN
and/CC
protein/NN
segregated/VBD
with/IN
DQA1/NN
allele/NN
,/,
because/IN
cell/NN
lines/NNS
bearing/VBG
DQA1*0501/DQB1*0201/NN
heterodimers/NNS
presented/VBD
antigen/NN
in/IN
proliferation/NN
and/CC
cytotoxicity/NN
assays/NNS
much/RB
more/RBR
efficiently/RB
than/IN
cell/NN
lines/NNS
bearing/VBG
DQA1*0201/DQB1*0201/NN
./.
=====
Binding/NN
of/IN
viral/JJ
peptide/NN
to/TO
cell/NN
lines/NNS
bearing/VBG
DQA1*0201/NN
,/,
in/IN
comparison/NN
to/TO
DQA1*0501/NN
,/,
was/VBD
only/RB
moderately/RB
reduced/VBN
and/CC
may/MD
not/RB
explain/VB
this/DT
effect/NN
./.
=====
Truncation/NN
and/CC
substitution/NN
analyses/NNS
of/IN
peptide/NN
binding/NN
and/CC
T-cell/NN
activation/NN
were/VBD
performed/VBN
to/TO
determine/VB
which/WDT
viral/JJ
peptide/NN
residues/NNS
contacting/VBG
TCR/NN
might/MD
therefore/RB
be/VB
presented/VBN
in/IN
an/DT
altered/JJ
conformation/NN
by/IN
DQA1*0201/DQB1*0201/NN
./.
=====
Residues/NNS
432/CD
,/,
435/CD
,/,
437/CD
,/,
438/CD
,/,
and/CC
440/CD
(/(
position/NN
P1/NN
,/,
P4/NN
,/,
P6/NN
,/,
P7/NN
,/,
and/CC
P9/NN
)/)
contributed/VBD
to/TO
DQ2/NN
binding/NN
,/,
whereas/IN
residues/NNS
431/CD
,/,
433/CD
,/,
434/CD
,/,
and/CC
436/CD
(/(
positions/NNS
P/NN
1/CD
,/,
P2/NN
,/,
P3/NN
,/,
and/CC
P5/NN
)/)
contributed/VBD
to/TO
TCR/NN
contact/NN
./.
=====
Differential/JJ
presentation/NN
of/IN
peptide/NN
by/IN
HLA/NN
DQ2/NN
heterodimers/NNS
varying/VBG
at/IN
the/DT
DQA1/NN
locus/NN
may/MD
have/VB
relevance/NN
to/TO
host/NN
defense/NN
and/CC
the/DT
pathogenesis/NN
of/IN
HLA/NN
DQ2-associated/JJ
autoimmune/JJ
diseases/NNS
./.